Bjoern Nashan

MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION

B. Nashan, M. Navarro, D. Kuypers, 2001, Transplantation.

Endoscopic management of biliary tract strictures in primary sclerosing cholangitis.

M. Manns, M. Gebel, B. Nashan, 1996, Endoscopy.

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re‐infection after liver transplantation

M. Manns, J. Klempnauer, S. Polywka, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Analysis of Risk Factors for Allograft Outcome Comparing 2 Kidneys From the Same Donor in Separate Recipients.

F. Thaiss, E. Achilles, B. Nashan, 2018, Transplantation proceedings.

Regarding “Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry”

A. Rahmel, P. Schemmer, B. Nashan, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients.

B. Nashan, H. Thude, A. Treszl, 2014, Tissue antigens.

Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid

F. Thaiss, E. Achilles, B. Nashan, 2016, Transplant infectious disease : an official journal of the Transplantation Society.